Currently there is no vaccine to prevent this virus and no specific antiviral therapy to treat HMPV, according to the CDC.

Currently there is no vaccine to prevent this virus and no specific antiviral therapy to treat HMPV, according to the CDC.

Adults aged 75 years or older should receive an RSV protein subunit vaccine; receipt can be considered for those aged 60 to 74 years at increased risk ...

Invivyd, Inc. (NASDAQ:IVVD) Q4 2025 Earnings Call Transcript March 5, 2026 Invivyd, Inc. misses on earnings expectations. Reported EPS is $-0.06428 EPS, expectations were $-0.06. Operator: Good day, ...

Human metapneumovirus (HMPV), a respiratory virus with no vaccine and no targeted antiviral treatment, is among the respiratory illnesses currently going around in the United States alongside ...

Doctors are warning people to stay vigilant as a seasonal flu virus that can lead to pneumonia and bronchitis spreads in ...

Less than 40% of surveyed adults view Health Secretary Kennedy as trustworthy, compared with 86% who have confidence in their ...

Through mass firings, rigged appointments, and unilateral decrees, HHS Secretary Kennedy is dismantling the federal machinery ...

A virus with no treatment or vaccine is rising in NJ, adding to flu, RSV and COVID cases in NJ. Here's the symptoms, how serious it is and more.

Flu cases are “very high” across much of Idaho, federal health experts say, and another respiratory virus is on the rise as ...

Achieved Q4 2025 PEMGARDA® (pemivibart) net product revenue of $17.2 million, representing 25% growth year-over-year and 31% growth ...